Global Uncertainty Drags Down Overseas Remittances Under LRS by 2 in FY26 RBI Data Shows Stereotaxis STXS Analyst Target Suggests Potential 1247 Upside Adani Enterprises Among Stocks Hitting 52Week Highs Rallying Up to 30 in a Month US Consumer Spending Rises Whats Driving the Resilience SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Navigates Pipeline Costs ORIO Q1 2026 Earnings NarrowerThanExpected Loss Signals Improved Cost Discipline EXFY Q1 2026 Earnings EPS Beats Estimates by 68 as Cost Discipline Drives Profitability Itron Inc ITRI Q1 2026 Earnings Earnings Beat Driven by Strong Operational Execution Compass Inc COMP Edges Higher as Real Estate Tech Sector Shows Resilience SOLV Energy Inc MWH Slides 35 Support Test Ahead as Resistance Holds Polaryx Therapeutics PLYX Retreats Toward Support Amid Selling Pressure Amylyx Pharmaceuticals AMLX Edges Higher Testing Key Resistance After Modest Gain Suzlon Energy Reports Mixed Q4 Results Profit Dips 6 YoY Revenue Surges 45 Plus500 Revenue Climbs 11 in Recent Quarter Company Affirms FullYear Guidance Singapore Manufacturing Output Rises in April Boosted by AIRelated Demand Ultragenyx RARE Rallies 29 as Biotech Sector Momentum Builds Global Uncertainty Drags Down Overseas Remittances Under LRS by 2 in FY26 RBI Data Shows Stereotaxis STXS Analyst Target Suggests Potential 1247 Upside Adani Enterprises Among Stocks Hitting 52Week Highs Rallying Up to 30 in a Month US Consumer Spending Rises Whats Driving the Resilience SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Navigates Pipeline Costs ORIO Q1 2026 Earnings NarrowerThanExpected Loss Signals Improved Cost Discipline EXFY Q1 2026 Earnings EPS Beats Estimates by 68 as Cost Discipline Drives Profitability Itron Inc ITRI Q1 2026 Earnings Earnings Beat Driven by Strong Operational Execution Compass Inc COMP Edges Higher as Real Estate Tech Sector Shows Resilience SOLV Energy Inc MWH Slides 35 Support Test Ahead as Resistance Holds Polaryx Therapeutics PLYX Retreats Toward Support Amid Selling Pressure Amylyx Pharmaceuticals AMLX Edges Higher Testing Key Resistance After Modest Gain Suzlon Energy Reports Mixed Q4 Results Profit Dips 6 YoY Revenue Surges 45 Plus500 Revenue Climbs 11 in Recent Quarter Company Affirms FullYear Guidance Singapore Manufacturing Output Rises in April Boosted by AIRelated Demand Ultragenyx RARE Rallies 29 as Biotech Sector Momentum Builds